ATC Group: R01AA Sympathomimetics, plain

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R01AA in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R01 Nasal preparations
3 R01A Decongestants and other nasal preparations for topical use
4 R01AA Sympathomimetics, plain

Group R01AA contents

Code Title
R01AA02 Cyclopentamine
R01AA03 Ephedrine
R01AA04 Phenylephrine
R01AA05 Oxymetazoline
R01AA06 Tetryzoline
R01AA07 Xylometazoline
R01AA08 Naphazoline
R01AA09 Tramazoline
R01AA10 Metizoline
R01AA11 Tuaminoheptane
R01AA12 Fenoxazoline
R01AA13 Tymazoline
R01AA14 Epinephrine
R01AA15

Active ingredients in R01AA

Active Ingredient Description
Ephedrine

Ephedrine is a sympathomimetic amine acting directly on the alpha and beta receptors and indirectly by increasing the release of noradrenaline by the sympathetic nerve endings. As with any sympathomimetic agent, ephedrine stimulates the central nervous system, the cardiovascular system, the respiratory system, and the sphincters of the digestive and urinary systems.

Epinephrine

Epinephrine is a direct acting sympathomimetic agent, which exerts effects on both α and β adrenoceptors. It has more pronounced effects on β than on α adrenoceptors, although α effects prevail at high doses. The effects of adrenaline include increased rate and force of cardiac contraction, cutaneous vasoconstriction and broncho-dilatation.

Fenoxazoline
Naphazoline

Naphazoline is a sympathomimetic amine with pronounced alpha adrenergic activity and as a consequence has vasoconstrictor activity.

Oxymetazoline

Oximetazoline is an imidazoline derivative. It exhibits sympathomimetic activity and specifically stimulates the α-adrenergic receptors of the sympathetic system. When administered topically to the nose it causes vasoconstriction of the expansed arterioles of the mucosal nose and a concurrent reduction in blood flow. It also reduces the hypersecretion of the nasal mucosa, ultimately contributing to the decongestion of the nasal mucosa.

Phenylephrine

Phenylephrine is a sympathomimetic agent with mainly direct effects on adrenergic receptors. It has predominantly alpha adrenergic activity and is without stimulating effects on the central nervous system. The sympathomimetic effect of phenylephrine produces vasoconstriction which in turn relieves nasal congestion.

Tetryzoline

Tetryzoline is an alpha adrenergic receptor agonist, which is used in form of nasal solution or spray for decongestion of nasal and nasopharyngeal mucosa.

Tramazoline

Tramazoline is an α-sympathomimetic agent with local action, which mainly causes vasoconstriction and therefore immediately reduces mucosal edema.

Tuaminoheptane
Xylometazoline

Xylometazoline acts directly on α-adrenoreceptors but does not act on β-receptors. When used topically as a nasal decongestant, xylometazoline acts rapidly and provides long-lasting relief. Onset of action is within minutes, the decongestant effect being prolonged and lasting for up to 10 hours.

Related product monographs

Title Information Source Document Type  
EPHEDRINE 1.0% Nasal drops Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
EPHEDRINE HYDROCHLORIDE Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
EPHEDRINE HYDROCHLORIDE Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
OTRIVIN ADULT Menthol Nasal spray, solution Health Products Regulatory Authority (IE) MPI, EU: SmPC
OTRIVINE ADULT Nasal spray, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
UTABON ADULTS Nasal spray, solution Medicines Authority (MT) MPI, EU: SmPC
UTABON PEDIATRIC Nasal drops, solution Medicines Authority (MT) MPI, EU: SmPC